Valerie Tsui-Wan Chan Teng, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Teng’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133593 · Current
Licensed to practise in California · since 2014 · expires 2028-09-30 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,346
Medicare paid this office $10,346 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 22 | $2,107 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $1,995 | $59 |
| Short return visit (20+ min) | 20 | $1,836 | $59 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 17 | $404 | $14 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 16 | $375 | $15 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 70 · Women 68% · Also on Medicaid 17% · Health risk score 1.13. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 52% · Diabetes 34% · Chronic kidney disease 22% · Cancer 20% · Coronary heart disease 16%.
The office billed $84,214, Medicare allowed $15,349 and paid $10,346; for 226 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 79 | 226 | 70 | 1.13 | $84,214 | $10,346 |
| 2023 | 77 | 179 | 72 | 1.04 | $76,569 | $10,045 |
| 2022 | 74 | 182 | 70 | 1.17 | $76,792 | $10,904 |
| 2021 | 53 | 153 | 72 | 1.10 | $58,311 | $10,015 |
| 2020 | 60 | 134 | 69 | 1.06 | $43,660 | $9,364 |
| 2019 | 62 | 123 | 70 | 1.29 | $17,483 | $7,513 |
| 2018 | 39 | 69 | 68 | 1.48 | $9,865 | $4,616 |
| 2017 | 83 | 165 | 69 | 1.42 | $29,268 | $10,478 |
| 2016 | 26 | 33 | 71 | 1.39 | $7,838 | $2,398 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 35 | $3,450 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $2,513 | $58 |
| Long return visit (40+ min) | 19 | $1,889 | $67 |
| Short return visit (20+ min) | 21 | $1,648 | $50 |
2022: 4 services
| Return visit (30+ min) | 40 | $4,130 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $1,936 | $59 |
| Short return visit (20+ min) | 27 | $1,734 | $50 |
| Long return visit (40+ min) | 14 | $1,302 | $72 |
2021: 4 services
| Return visit (30+ min) | 31 | $3,507 | $65 |
| Long return visit (40+ min) | 14 | $1,277 | $61 |
| Short return visit (20+ min) | 16 | $1,199 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $932 | $72 |
2020: 3 services
| Return visit (30+ min) | 33 | $4,186 | $70 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,369 | $47 |
| Short return visit (20+ min) | 11 | $479 | $40 |
2019: 2 services
| Return visit (30+ min) | 28 | $3,301 | $63 |
| Short return visit (20+ min) | 28 | $1,671 | $41 |
2018: 1 service
| Return visit (30+ min) | 21 | $1,695 | $63 |
2017: 3 services
| Return visit (30+ min) | 40 | $4,600 | $65 |
| Short return visit (20+ min) | 45 | $2,328 | $42 |
| New patient visit (30+ min) | 11 | $679 | $62 |
Drugs they prescribed that Part D paid
$93,180
Pharmacies billed $93,180 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (27 of 719) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 56% of their opioid prescriptions.
603 generic and 102 brand-name prescriptions · $93,180 in drug cost · 25 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 12 | $14,724 | $1,227 |
| Ozempic | 11 | $13,541 | $1,231 |
| Gabapentin | 51 | $3,883 | $76 |
| Buprenorphine | 12 | $3,382 | $282 |
| Desipramine | 12 | $1,357 | $113 |
See all 15 drugs
| Mounjaro | 12 | $14,724 | $1,227 |
| Ozempic | 11 | $13,541 | $1,231 |
| Gabapentin | 51 | $3,883 | $76 |
| Buprenorphine | 12 | $3,382 | $282 |
| Desipramine | 12 | $1,357 | $113 |
| Celecoxib | 17 | $576 | $34 |
| Omeprazole | 19 | $474 | $25 |
| Losartan | 39 | $421 | $11 |
| Atorvastatin | 19 | $351 | $18 |
| Chlorthalidone | 14 | $305 | $22 |
| Rosuvastatin | 31 | $283 | $9 |
| Fluticasone Propionate | 13 | $184 | $14 |
| Metformin Hcl Er | 15 | $121 | $8 |
| Levothyroxine | 13 | $70 | $5 |
| Amlodipine Besylate | 16 | $56 | $4 |
Year by year
| 2024 | 719 | 78 | 4% (27) | 14% | $93,180 |
| 2023 | 907 | 98 | 5% (43) | None | $102,732 |
| 2022 | 929 | 101 | 3% (23) | None | $98,146 |
| 2021 | 684 | 78 | 3% (20) | None | $71,254 |
| 2020 | 639 | 70 | 2% (14) | None | $70,781 |
| 2019 | 580 | 72 | 4% (24) | None | $63,630 |
| 2018 | 493 | 58 | 4% (20) | 15% | $34,975 |
| 2017 | 723 | 78 | 8% (56) | 18% | $53,589 |
| 2016 | 228 | 42 | 5% (11) | None | $10,673 |
| 2015 | 88 | 32 | None | None | $2,436 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Eliquis | 12 | $14,559 | $1,213 |
| Ozempic | 13 | $14,358 | $1,104 |
| Buprenorphine | 13 | $3,672 | $282 |
| Gabapentin | 55 | $1,864 | $34 |
| Losartan | 49 | $856 | $17 |
| Atorvastatin | 47 | $730 | $16 |
| Estradiol (Twice Weekly) | 11 | $679 | $62 |
| Rosuvastatin | 31 | $674 | $22 |
| Omeprazole | 21 | $631 | $30 |
| Levothyroxine | 31 | $531 | $17 |
| Hydroxyzine | 11 | $511 | $46 |
| Chlorthalidone | 20 | $481 | $24 |
| Baclofen | 19 | $434 | $23 |
| Celecoxib | 11 | $392 | $36 |
| Metformin | 19 | $311 | $16 |
| Fluticasone Propionate | 15 | $270 | $18 |
| Amlodipine Besylate | 11 | $261 | $24 |
| Pantoprazole | 13 | $253 | $19 |
| Diclofenac | 11 | $171 | $16 |
| Ibuprofen | 16 | $160 | $10 |
| Simvastatin | 19 | $152 | $8 |
| Alendronate | 14 | $146 | $10 |
| Prednisone | 17 | $136 | $8 |
| Lisinopril | 18 | $126 | $7 |
| Hydrocodone-Acetaminophen | 11 | $96 | $9 |
| Hydrochlorothiazide | 29 | $89 | $3 |
| Alprazolam | 15 | $59 | $4 |
2022: 27 drugs
| Jardiance | 11 | $16,322 | $1,484 |
| Eliquis | 17 | $14,170 | $834 |
| Ozempic | 15 | $12,999 | $867 |
| Levothyroxine | 50 | $1,012 | $20 |
| Atorvastatin | 62 | $864 | $14 |
| Gabapentin | 48 | $697 | $15 |
| Diclofenac | 21 | $639 | $30 |
| Losartan | 40 | $574 | $14 |
| Estradiol | 14 | $486 | $35 |
| Diltiazem 24hr Er (Cd) | 11 | $431 | $39 |
| Baclofen | 19 | $414 | $22 |
| Rosuvastatin | 11 | $407 | $37 |
| Ibuprofen | 21 | $386 | $18 |
| Omeprazole | 23 | $361 | $16 |
| Metformin | 16 | $343 | $21 |
| Lisinopril | 30 | $308 | $10 |
| Chlorthalidone | 12 | $307 | $26 |
| Fluticasone Propionate | 19 | $303 | $16 |
| Amlodipine Besylate | 21 | $247 | $12 |
| Simvastatin | 20 | $244 | $12 |
| Metoprolol | 11 | $205 | $19 |
| Alendronate | 15 | $193 | $13 |
| Donepezil | 19 | $156 | $8 |
| Pantoprazole | 16 | $139 | $9 |
| Hydrochlorothiazide | 26 | $105 | $4 |
| Alprazolam | 13 | $49 | $4 |
| Triamterene-Hydrochlorothiazid | 12 | $33 | $3 |
2021: 17 drugs
| Ozempic | 14 | $11,543 | $825 |
| Jardiance | 13 | $8,155 | $627 |
| Humalog | 15 | $4,416 | $294 |
| Losartan | 38 | $724 | $19 |
| Levothyroxine | 26 | $671 | $26 |
| Atorvastatin | 42 | $559 | $13 |
| Gabapentin | 44 | $539 | $12 |
| Ibuprofen | 15 | $294 | $20 |
| Baclofen | 21 | $241 | $11 |
| Trazodone | 12 | $202 | $17 |
| Lisinopril | 17 | $173 | $10 |
| Sumatriptan | 14 | $145 | $10 |
| Metformin | 13 | $125 | $10 |
| Alprazolam | 12 | $125 | $10 |
| Alendronate | 12 | $97 | $8 |
| Hydrochlorothiazide | 25 | $73 | $3 |
| Amlodipine Besylate | 11 | $67 | $6 |
2020: 21 drugs
| Trulicity | 13 | $14,797 | $1,138 |
| Jardiance | 16 | $8,305 | $519 |
| Levothyroxine | 23 | $737 | $32 |
| Bupropion Xl | 14 | $728 | $52 |
| Ventolin Hfa | 11 | $635 | $58 |
| Atorvastatin | 33 | $630 | $19 |
| Losartan | 40 | $564 | $14 |
| Gabapentin | 31 | $546 | $18 |
| Albuterol Sulfate Hfa | 12 | $444 | $37 |
| Fluoxetine | 11 | $321 | $29 |
| Omeprazole | 16 | $301 | $19 |
| Promethazine | 17 | $248 | $15 |
| Sumatriptan | 13 | $241 | $19 |
| Lisinopril | 19 | $210 | $11 |
| Metformin | 15 | $170 | $11 |
| Ibuprofen | 11 | $165 | $15 |
| Methadone | 11 | $138 | $13 |
| Simvastatin | 12 | $116 | $10 |
| Alendronate | 12 | $114 | $9 |
| Alprazolam | 11 | $92 | $8 |
| Hydrochlorothiazide | 18 | $79 | $4 |
2019: 16 drugs
| Victoza 3-Pak | 15 | $13,524 | $902 |
| Advair Diskus | 15 | $4,927 | $328 |
| Humalog | 11 | $3,238 | $294 |
| Levothyroxine | 20 | $606 | $30 |
| Gabapentin | 27 | $463 | $17 |
| Lisinopril | 20 | $214 | $11 |
| Atorvastatin | 20 | $210 | $10 |
| Losartan | 25 | $204 | $8 |
| Bupropion Xl | 14 | $183 | $13 |
| Glipizide | 13 | $144 | $11 |
| Methadone | 12 | $134 | $11 |
| Cyclobenzaprine | 13 | $95 | $7 |
| Promethazine | 12 | $86 | $7 |
| Ibuprofen | 15 | $83 | $6 |
| Alprazolam | 11 | $83 | $8 |
| Hydrochlorothiazide | 15 | $67 | $4 |
2018: 11 drugs
| Clinisol | 15 | $5,393 | $360 |
| Gabapentin | 40 | $776 | $19 |
| Digox | 11 | $338 | $31 |
| Bupropion Xl | 13 | $260 | $20 |
| Atorvastatin | 17 | $258 | $15 |
| Fluoxetine | 14 | $214 | $15 |
| Lisinopril | 20 | $180 | $9 |
| Losartan | 22 | $170 | $8 |
| Hydrocodone-Acetaminophen | 11 | $123 | $11 |
| Pantoprazole | 13 | $114 | $9 |
| Spironolactone | 12 | $79 | $7 |
2017: 20 drugs
| Clinisol | 39 | $13,704 | $351 |
| Lantus Solostar | 15 | $6,349 | $423 |
| Advair Diskus | 13 | $3,859 | $297 |
| Gabapentin | 59 | $902 | $15 |
| Ventolin Hfa | 14 | $751 | $54 |
| Atorvastatin | 34 | $681 | $20 |
| Levothyroxine | 20 | $406 | $20 |
| Bupropion Xl | 12 | $328 | $27 |
| Hydrocodone-Acetaminophen | 25 | $306 | $12 |
| Lisinopril | 21 | $259 | $12 |
| Trazodone | 12 | $248 | $21 |
| Metformin | 19 | $203 | $11 |
| Pantoprazole | 13 | $177 | $14 |
| Omeprazole | 16 | $171 | $11 |
| Simvastatin | 15 | $162 | $11 |
| Losartan | 19 | $131 | $7 |
| Citalopram Hbr | 13 | $115 | $9 |
| Allopurinol | 13 | $69 | $5 |
| Hydrochlorothiazide | 15 | $55 | $4 |
| Lorazepam | 14 | $34 | $2 |
2016: 4 drugs
| Lantus Solostar | 11 | $4,697 | $427 |
| Atorvastatin | 14 | $294 | $21 |
| Metformin | 13 | $89 | $7 |
| Simvastatin | 19 | $46 | $2 |
2015: 1 drug
| Simvastatin | 14 | $45 | $3 |
Professional record
- NPI
- 1346680568
- Licence
- CA A133593California A133593: Current · expires 2028-09-30
- Trained
- University of California, Irvine, California College of Medicine, 2013
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-07-02
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd, Palo Alto, CA, 94304